Pancreatic Cancer Research

ResearcherUniversity of North Carolina at Chapel HillActive in the last 2 years

Hong Joo Kim

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4121-6329; OpenAlex author ID A5101598003. Sources: OpenAlex.

Their work

Papers
7 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
1
Collaborators
34
Papers, trials and grants by year

2018: 1 paper · 2019: 1 paper · 2020: 2 papers · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper

Papers 7

  1. Lymph node metrics following neoadjuvant therapy to refine patient selection for adjuvant chemotherapy in resected pancreatic cancer: A multi-institutional ana… Co-author DOI 10.1002/jso.27798↗
  2. Racial Disparity in Pathologic Response following Neoadjuvant Chemotherapy in Resected Pancreatic Cancer: A Multi-Institutional Analysis from the Central Pancr… Co-author DOI 10.1245/s10434-022-12741-4↗
  3. Intraoperative Pancreatic Neck Margin Assessment During Pancreaticoduodenectomy for Pancreatic Adenocarcinoma in the Era of Neoadjuvant Therapy: A Multi-instit… Co-author DOI 10.1245/s10434-022-11804-w↗
  4. Middle-aged men with type 2 diabetes as potential candidates for pancreatic cancer screening: a 10-year nationwide population-based cohort study. Co-author DOI 10.1007/s00592-019-01405-7↗
  5. Glycemic Status, Insulin Resistance, and Risk of Pancreatic Cancer Mortality in Individuals With and Without Diabetes. Last author DOI 10.14309/ajg.0000000000000956↗
  6. Survival Outcomes Associated With Clinical and Pathological Response Following Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Chemotherapy in Resected Pa… Co-author DOI 10.1097/sla.0000000000003468↗
  7. Preoperative risk factors for early recurrence in patients with resectable pancreatic ductal adenocarcinoma after curative intent surgical resection. First author DOI 10.1016/j.hbpd.2018.09.003↗

Closest collaborators

The 25 strongest of 34 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. David A. Kooby · 4 shared papers, 2019–2024 · strength 0.51
  2. Daniel Erik Abbott · 4 shared papers, 2019–2024 · strength 0.51
  3. Nipun B. Merchant · 4 shared papers, 2019–2024 · strength 0.51
  4. Shishir Kumar Maithel · 4 shared papers, 2019–2024 · strength 0.51
  5. Gregory C. Wilson · 3 shared papers, 2022–2024 · strength 0.44
  6. Chet W. Hammill · 3 shared papers, 2022–2024 · strength 0.44
  7. Syed Ameen Ahmad · 3 shared papers, 2019–2023 · strength 0.35
  8. Nam Hee Kim · 2 shared papers, 2018–2020 · strength 0.32
  9. Ifeanyichukwu Chinedu Ogobuiro · 2 shared papers, 2023–2024 · strength 0.31
  10. Alexander A. Parikh · 2 shared papers, 2023–2024 · strength 0.31
  11. Rebecca Anne Snyder · 2 shared papers, 2023–2024 · strength 0.31
  12. Jashodeep Datta · 2 shared papers, 2022–2023 · strength 0.28
  13. Patrick Beard Schwartz · 2 shared papers, 2019–2023 · strength 0.22
  14. Robert C.G. Martin · 2 shared papers, 2019–2022 · strength 0.21
  15. Dong‐Hoe Koo · 1 shared paper, 2020 · strength 0.16
  16. Kyungdo Han · 1 shared paper, 2020 · strength 0.16
  17. Cheol‐Young Park · 1 shared paper, 2020 · strength 0.16
  18. Erin M. Dickey · 1 shared paper, 2024 · strength 0.16
  19. Caitlin A. Hester · 1 shared paper, 2024 · strength 0.16
  20. Jashodeep Datta · 1 shared paper, 2024 · strength 0.16
  21. Haleh Amirian · 1 shared paper, 2024 · strength 0.16
  22. Mary P Martos · 1 shared paper, 2024 · strength 0.16
  23. Syed Arif Ahmad · 1 shared paper, 2024 · strength 0.16
  24. Syed Nabeel Zafar · 1 shared paper, 2024 · strength 0.16
  25. Iago De Castro Silva · 1 shared paper, 2023 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.